What is Institutional Eye Care?
Institutional Eye Care operates as the preeminent provider of on-site vision services within the American correctional system, a niche yet essential segment of the healthcare infrastructure. With a legacy spanning over four decades, the organization manages a sophisticated network of more than 150 licensed optometrists and ophthalmologists. By delivering comprehensive clinical care—ranging from routine refractions to complex ophthalmological diagnostics—the company ensures that correctional facilities maintain compliance with federal safety standards while providing necessary medical attention to incarcerated populations. Their ability to scale across 35 states demonstrates a high barrier to entry and a defensible market position in a highly specialized medical field.
How much funding has Institutional Eye Care raised?
Institutional Eye Care has raised a total of $383K across 2 funding rounds:
Debt
$150K
Debt
$233K
Debt (2020): $150K with participation from PPP
Debt (2021): $233K led by PPP
Key Investors in Institutional Eye Care
PPP
Public-Private Partnership
Undisclosed Investors
Undisclosed Investors
What's next for Institutional Eye Care?
With the recent infusion of capital, Institutional Eye Care is well-positioned to optimize its service delivery model and potentially expand its footprint into additional jurisdictions. The company's focus on integrating advanced diagnostic technology and streamlining the supply chain for prescription eyewear will likely remain a priority. As the firm continues to leverage its extensive network, the strategic deployment of these funds will be instrumental in maintaining its competitive advantage and addressing the growing demand for standardized, high-quality vision care within the institutional sector. Future growth will likely center on operational efficiency and the deepening of existing state-level partnerships.
See full Institutional Eye Care company page
